Document Detail

Effects of single doses of quinapril and atenolol on autonomic nervous function and exercise capacity in healthy volunteers.
MedLine Citation:
PMID:  2197098     Owner:  NLM     Status:  MEDLINE    
The effects of single oral doses of the angiotensin converting enzyme (ACE) inhibitor quinapril (CI-906) 40 mg and the cardioselective beta-adrenoceptor blocker atenolol 100 mg on sympathetic and parasympathetic function and on exercise capacity have been studied in 8 healthy young men. The trial followed a double-blind, placebo controlled, randomized cross-over design, with at least one week between treatments. Blood pressure (BP) and heart rate (HR) at rest were slightly reduced by atenolol but were not affected by quinapril. Atenolol impaired the sympathetically mediated increases in HR and BP caused by standing, immersion of the hand into melting ice, the Valsalva manoeuvre and isometric forearm exercise. Quinapril did not influence those responses nor the vagally mediated bradycardia of the diving reflex. Atenolol, however, augmented the vagal bradycardia, presumably by sympathetic inhibition. In a dynamic bicycle ergometer test with a stepwise increasing work load, exercise performance was decreased by atenolol but not by quinapril. Inhibition of the renin-angiotensin system by quinapril was shown by a marked decrease in serum ACE activity and a several-fold increase in plasma renin activity (PRA). Atenolol produced a moderate reduction in PRA. Before or during exercise, plasma noradrenaline and adrenaline were not influenced by either drug. The results indicate that, unlike the atenolol-induced beta-adrenoceptor blockade, ACE inhibition by a single dose of quinapril had no clear effect on autonomic nervous function or exercise capacity.
I Pörsti; P Arvola; P Säynävälammi; A K Nurmi; T Metsä-Ketelä; K Koskenvuo; L A Laitinen; V Manninen; H Vapaatalo
Related Documents :
37868 - Onset and duration of beta-adrenergic receptor blockade following single oral dose aceb...
1399898 - Responses of calves to treadmill exercise during beta-adrenergic agonist administration.
9229238 - Autonomic nervous control of heart rate orienting and alpha responses in dog.
21765268 - Rehabilitation and exercise considerations in hematologic malignancies.
2715788 - Adaptation by older individuals repeatedly exposed to 0.45 parts per million ozone for ...
24722218 - Positive exercise experience facilitates behavior change via self-efficacy.
Publication Detail:
Type:  Clinical Trial; Journal Article; Randomized Controlled Trial    
Journal Detail:
Title:  European journal of clinical pharmacology     Volume:  38     ISSN:  0031-6970     ISO Abbreviation:  Eur. J. Clin. Pharmacol.     Publication Date:  1990  
Date Detail:
Created Date:  1990-08-29     Completed Date:  1990-08-29     Revised Date:  2008-11-21    
Medline Journal Info:
Nlm Unique ID:  1256165     Medline TA:  Eur J Clin Pharmacol     Country:  GERMANY, WEST    
Other Details:
Languages:  eng     Pagination:  541-6     Citation Subset:  IM    
Department of Biomedical Sciences, University of Tampere, Finland.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Atenolol / pharmacology*
Autonomic Nervous System / drug effects*
Blood Pressure / drug effects
Cold Temperature
Double-Blind Method
Epinephrine / blood
Heart / drug effects
Heart Rate / drug effects
Isoquinolines / pharmacology*
Norepinephrine / blood
Renin / blood
Valsalva Maneuver
Reg. No./Substance:
0/Isoquinolines; 0/Tetrahydroisoquinolines; 29122-68-7/Atenolol; 51-41-2/Norepinephrine; 51-43-4/Epinephrine; 82586-55-8/quinapril; EC

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  The interpretation of oesophageal pH monitoring data.
Next Document:  Metamizole: reassessment of its therapeutic role.